HAOHAI BIOTEC(06826)

28.400+1.650+6.17%

Market data delayed 15 minutes

    • Smartkarma
      ·
      2022-05-19

      Shanghai Haohai Biological Technology (688366CH)- Diversified Business Layout Doesn't Secure Outlook

      Haohai builds diversified business via M&A,but none is growth point with high certainty. Its medical aesthetics has no obvious advantage and the valuation would be lower due to centralized procurement Haohai's development is fuelled by a series of acquisitions, which help Haohai establish the existing diversified businesses, but we haven’t seen any growth point with high certainty. Compared with Bloomage and Imeik, Haohai has no competitive advantage in the field of medical aesthetics. It’s also difficult for Haohai to make a substantial breakthrough without obvious product advantages. Although Haohai’s PE/TTM is significantly lower than its peers, due to centralized procurement, Haohai’s valuation could be further lower. Considering the risks, we choose to stay cautious on Haohai
      Shanghai Haohai Biological Technology (688366CH)- Diversified Business Layout Doesn't Secure Outlook
      16
      Report
    • Company Profile

      Company Name
      HAOHAI BIOTEC
      Market
      SEHK
      Establishment Date
      - -
      Employees
      - -
      Office Location
      - -
      Zip Code
      - -
      Phone
      - -
      Fax
      - -
      Introduction
      Shanghai Haohai Biological Technology Co., Ltd. is a China-based company principally engaged in biological technology-related businesses. The businesses of the Company include the manufacture and sales of biological and medical hyaluronate, the research and development of biological engineering and pharmaceutical products and the provision of related services. Its products include orthopedics products, medical aesthetics and wound care products, ophthalmology products and anti-adhesion and hemostasis products, among others. Orthopedics products include sodium hyaluronate injection, medical chitosan and medical sodium hyaluronate gel. Medical aesthetics and wound care products include recombinant human epidermal growth factor (rhEGF), among others. Ophthalmology products include ophthalmic viscoelastic devices and lubricant eye drops. Anti-adhesion and hemostasis products include medical collagen sponges, among others. The Company mainly operates businesses in Mainland China.
      • 1D
      • 5D
      • Day
      • Week
      • Month
      Loading ...
      High
      28.400
      Open
      27.200
      Volume%
      2.67
      Low
      26.900
      Close
      26.750
      T/O Rate
      2.00%
      errorbox banner

      抱歉,当前请求异常(-1)

      Company: TTMF Limited. Tech supported by Xiangshang Yixin.

      Email:uservice@ttm.financial